|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.31 CAD | 0.00% |
|
-2.94% | -5.54% |
| 01-09 | Bright Minds Biosciences Closes its US$175 Million Public Offering | MT |
| 01-09 | Bright Minds Biosciences Closes $175.1 Million Stock Offering | MT |
Company Valuation: Bright Minds Biosciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 107 | 8.11 | 6.562 | 598.2 | 1,015 | - | - |
| Change | - | - | -19.09% | 9,016.5% | 69.7% | - | - |
| Enterprise Value (EV) | 107 | 8.11 | 6.562 | 598.2 | 1,015 | 1,015 | 1,015 |
| Change | - | - | -19.09% | 9,016.5% | 69.7% | 0% | 0% |
| P/E ratio | - | -1.09x | - | -47.4x | -13.5x | -8x | -7.96x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | - | - | - | -0x | -0.1x | -14.73x |
| Capitalization / Revenue | - | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | -0x | -9.82x | -4.91x | -3.51x |
| EV / EBIT | - | - | - | -0x | -12x | -5.54x | -4.35x |
| EV / FCF | - | - | - | -0x | -10.5x | -5.33x | -3.96x |
| FCF Yield | - | - | - | -1.45% | -9.52% | -18.8% | -25.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | - | -1.98 | - | -1.78 | -7.746 | -13.04 | -13.11 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - |
| EBITDA 1 | - | - | - | -13.67 | -103.4 | -206.8 | -289.6 |
| EBIT 1 | - | - | - | -13.75 | -84.47 | -183.3 | -233.3 |
| Net income 1 | - | -7.372 | - | -12.23 | -82.77 | -180.6 | -214.8 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 45.20 | 2.15 | 1.47 | 84.39 | 104.31 | 104.31 | 104.31 |
| Nbr of stocks (in thousands) | 2,367 | 3,772 | 4,464 | 7,089 | 9,732 | - | - |
| Announcement Date | 29/12/21 | 29/12/23 | 31/12/24 | 24/12/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -13.47x | - | - | - | 744M | ||
| 36.2x | 5.26x | 17.62x | 0.95% | 46.82B | ||
| 108.48x | 6.96x | 69.61x | -.--% | 39.16B | ||
| 58.42x | 11.94x | 33.41x | 0.33% | 32.9B | ||
| 26.51x | 2.79x | 11.94x | -.--% | 31.8B | ||
| -17.45x | 4983.42x | -16.28x | -.--% | 18.85B | ||
| 36.62x | 5.92x | 26.9x | -.--% | 15.27B | ||
| Average | 33.62x | 836.05x | 23.87x | 0.21% | 26.51B | |
| Weighted average by Cap. | 48.12x | 514.15x | 27.78x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- DRUG Stock
- Valuation Bright Minds Biosciences Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















